European Lentigo Maligna Diagnostics and Therapeutics survey


12 Jun 2015


Dear Colleague,

The VU University medical center, Amsterdam, the Netherlands, is currently conducting an (anonymous) online survey among EADV members in Europe regarding Lentigo Maligna (LM), investigating the treatment modalities and diagnostics since there is no clear gold standard available.

Our current response rate is 11% of the 2298 invited dermatologists and dermatology trainees, and therefore we are writing you to ask for your support. We would like to ask if you could help to increase the exposure of our survey to your colleagues.

On 26-may-2015 we will send the last reminder about the survey, which will close on 12-june-2015. We would kindly ask you to remind your colleagues to respond to the survey.

Since the results might have serious implications for the treatment of our LM patients, this research is considered very valuable. Your response is therefore of great importance to us.

If you have any questions regarding the survey, do not hesitate to contact us.

Kind regards,

Darryl Tio, dermatology trainee & Catherine (Bibi) van Montfrans, dermatologist


Recapiti

VU medical center
Amsterdam

Contatti

Darryl Tio & Catherine (Bibi) van Montfrans

Telefono Non disponibile
Richiesta informazioni

SIDeMaST è su Facebook

Gli eventi SIDeMaST li trovi anche su Facebbok.